2021-2022 Adult Flu Vaccine

Award Notice Posted

Solicitation number
75D301-20-R-68174
Agency
Awarded
to Astrazeneca Pharmaceuticals LP
Set-aside
No set-aside

Opportunity facts

Contract number
75D30121D10217 Federal IDV award
Place of performance
Wilmington DE 19803 USA

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services announces the award of an IDIQ contract to AstraZeneca Pharmaceuticals LP for adult flu vaccines. The contract number is 75D30121D10217 and has a ceiling value of $131,584,000. The contract was awarded on December 28, 2020 to provide 131584000 worth of adult flu vaccines through an indefinite delivery/indefinite quantity arrangement.

Notice text

Notice of award for RFP 75D301-20-R-68174

ASTRAZENECA PHARMACEUTICALS LP

1800 CONCORD PIKE

WILMINGTON, DE 19803-2902

Contract Number: 75D30121D10217
IDIQ Ceiling: $131,584,000.00

Awarded contract 75D30121D10217 to ASTRAZENECA PHARMACEUTICALS LP for 131584000.00 on 2020-12-28.

Notice history

Notice Type Posted
2021-2022 Adult Flu Vaccine Latest Award Notice
2021-2022 Adult Flu Vaccine Award Notice
2021-2022 Adult Flu Vaccine Award Notice
This notice Award Notice
2021 Adult Flu Vaccine Latest solicitation Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response Washington, District of Columbia 20024, United States · NAICS 541714 Office of the Assistant Secretary for Preparedness and Response No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors